Recruiting NA Cerebral Autoregulation Mapping

New treatment option for Cerebral Autoregulation Mapping

Official title Non-Invasive Mapping of Cerebral Autoregulation Using Near Infrared Spectroscopy

ClinicalTrials.gov ID: NCT05433129

What this study is testing

What it's testing
The investigators propose to employ advanced multi-channel near non-invasive near infrared spectroscopy (NIRS) system married with entirely non-invasive continuous arterial blood pressure (niABP) monitor to create a new wearable and portable imaging system that derives CA maps of the entire brain with high sampling rates at each point. The objectives of this project are as follows: 1.
  • Time commitment: about 18 months

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 and older. Healthy volunteers may be eligible.

You may be able to join if

  • Healthy volunteers (male and female)
  • Age \> 17

You likely can't join if

  • History of neurological illness
  • History of systemic vascular
  • History of cerebrovascular disease

The study team makes the final eligibility decision.

Where it's taking place

  • Winnipeg, Manitoba, Canada

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The study runs about 18 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Winnipeg, Manitoba, Canada. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.